CRP and breast cancer: Systemic inflammatory markers such as C-reactive protein (CRP), neutrophil-to-lymphocyte ratio (NLR), monocyte-to-lymphocyte ratio (MLR), and platelet-to-lymphocyte ratio (PLR) have been identified as potential prognostic and predictive indicators in various malignancies, including breast cancer.